“…However, the primary consideration as designing any drug delivery system is to control the drug concentration in the therapeutic window, while plummeting side effects and improving patient compliance. This allows useful treatment cycles to be maintained, and at the same time decreases damage to healthy cells and diminishes the recovery period (Peer et al, 2007;Davis, 2008;Lammers et al, 2008;Dinarvand et al, 2011). Poly (lactic-coglycolic acid) (PLGA) is one of the most successfully used biodegradable polymers because its hydrolysis leads to metabolite monomers, lactic acid and glycolic acid.…”